We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Psychedelics

$2.7 Million Federal Grant Will Fund Study to Find New Psychedelics

By Leo Bear-McGuinness

Published: May 24, 2022   

Complete the form below and we will email you a PDF version of "$2.7 Million Federal Grant Will Fund Study to Find New Psychedelics"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

$2.7 Million Federal Grant Will Fund Study to Find New Psychedelics

Psychedelic drugs are at the forefront of a new age of therapy. Substances like MDMA and the magic mushroom compound psilocybin have shown great potential to help treat mental health disorders such as PTSD, addiction, and depression.

But will these chemicals be enough? That’s the question on the mind of a group of researchers from the University of California, Davis, and the University of Colorado Anschutz Medical Campus. They’re about to start a new project to discover new, non-hallucinogenic treatments for substance use disorders.

Hundreds of compounds will be screened and tested to see if they can rewire parts of the brain to help people better cope with depression and substance abuse disorders. Promising compounds will undergo further animal testing at CU Anschutz.

The study to search for these psychoplastogens, as they’re so termed, has been funded by a $2.7 million grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

“I’m very excited that NIDA is recognizing the potential that psychoplastogens might have for patients with substance use disorders,” David Olson, an associate professor in the departments of Chemistry, and Biochemistry and Molecular Medicine at UC Davis, said in a statement.

“This grant will help us to understand the basic mechanisms by which these compounds impact addiction, and hopefully develop more effective and better tolerated treatments.”

The study will build upon Olsen’s existing work at UC Davis. His lab has previously synthesized hundreds of molecules related to psychedelics in the search for new drug therapies. One such chemical, tabernanthalog (TBG), produced both rapid and sustained anti-addictive effects in rodent models of heroin and alcohol self-administration. 

In addition to searching for new compounds with psychoplastogenic effects, the new research project will include mechanistic studies to understand how TBG impacts addiction. and the development of new compounds, he said.

 

Like what you just read? You can find similar content on the topic tags shown below.

Science & Health Psychedelics

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement